The appropriate antibiotic treatment of respiratory tract infections involv
es accurate diagnosis and identification of bacterial infection, with treat
ment targeted at the infecting pathogens. Optimal drug selection is based o
n predicted bacterial susceptibility, drug distribution and activity in the
respiratory tract, and safety for the patient; however, treatment is often
required before results of culture and sensitivity tests are completed. Ad
ditionally, these infections are often the result of underlying disease pro
cesses that predispose the patient to secondary bacterial infection and may
complicate the response to therapy. This article presents an overview of t
he unique physiology and defense mechanisms of the respiratory system, the
diversity of microbial organisms that may colonize and invade the respirato
ry tract, and the factors that affect antimicrobial therapy in the diseased
state in dogs and cats.